Vitalhub (TSE:VHI) Hits New 12-Month High at $7.97

Vitalhub Corp. (TSE:VHIGet Free Report)’s stock price reached a new 52-week high during mid-day trading on Monday . The stock traded as high as C$7.97 and last traded at C$7.84, with a volume of 130188 shares traded. The stock had previously closed at C$7.81.

Analysts Set New Price Targets

Several equities research analysts have issued reports on VHI shares. Cormark increased their target price on Vitalhub from C$7.50 to C$8.00 in a research report on Tuesday, June 11th. Canaccord Genuity Group increased their target price on Vitalhub from C$7.50 to C$8.00 and gave the stock a “buy” rating in a research report on Monday, May 13th.

Get Our Latest Analysis on VHI

Vitalhub Stock Down 1.2 %

The stock has a market cap of C$391.33 million, a PE ratio of 77.10, a P/E/G ratio of 2.61 and a beta of 1.23. The company has a fifty day moving average price of C$6.67 and a 200 day moving average price of C$5.62.

Vitalhub (TSE:VHIGet Free Report) last released its quarterly earnings data on Thursday, May 9th. The company reported C$0.04 EPS for the quarter, missing the consensus estimate of C$0.07 by C($0.03). The company had revenue of C$15.26 million during the quarter, compared to analysts’ expectations of C$14.12 million. Vitalhub had a return on equity of 5.78% and a net margin of 8.66%. As a group, research analysts predict that Vitalhub Corp. will post 0.2700115 earnings per share for the current year.

Vitalhub Company Profile

(Get Free Report)

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.

Read More

Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with's FREE daily email newsletter.